Depakote ER in Borderline Personality Disorder
NCT00222482
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Borderline Personality Disorder
Interventions
DRUG:
Depakote ER
Sponsor
University of Minnesota
Collaborators
[object Object]
[object Object]